---
title: "12 Health Care Stocks Moving In Thursday's Pre-Market Session"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/292903745.md"
description: "In Thursday's pre-market session, several healthcare stocks saw significant movement. Gainers included AtaiBeckley (ATAI) up 34.3%, Agape ATP (ATPC) up 27.77%, and Liminatus Pharma (LIMN) up 23.23%. Conversely, losers featured CDT Equity (CDT) down 19.8% following Q1 earnings, Decoy Therapeutics (DCOY) down 12.46%, and Entera Bio (ENTX) down 11.24% after FY earnings releases."
datetime: "2026-07-16T12:05:43.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/292903745.md)
  - [en](https://longbridge.com/en/news/292903745.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/292903745.md)
---

# 12 Health Care Stocks Moving In Thursday's Pre-Market Session

### Gainers

-   **AtaiBeckley** (NASDAQ:ATAI) stock rose 34.3% to $7.2 during Thursday's pre-market session. The market value of their outstanding shares is at $1.9 billion.
-   **Agape ATP** (NASDAQ:ATPC) shares moved upwards by 27.77% to $3.22. The market value of their outstanding shares is at $2.5 million.
-   **Liminatus Pharma** (NASDAQ:LIMN) shares increased by 23.23% to $0.14. The company's market cap stands at $7.6 million.
-   **GH Research** (NASDAQ:GHRS) shares rose 17.75% to $31.7. The market value of their outstanding shares is at $1.8 billion.
-   **Virax Biolabs Group** (NASDAQ:VRAX) stock increased by 16.23% to $4.01. The market value of their outstanding shares is at $2.7 million.
-   **Kairos Pharma** (AMEX:KAPA) stock moved upwards by 12.16% to $0.36. The market value of their outstanding shares is at $6.8 million.

### Losers

-   **CDT Equity** (NASDAQ:CDT) stock decreased by 19.8% to $0.28 during Thursday's pre-market session. The market value of their outstanding shares is at $1.7 million. As per the press release, Q1 earnings came out yesterday.
-   **Decoy Therapeutics** (NASDAQ:DCOY) shares declined by 12.46% to $5.41. The market value of their outstanding shares is at $3.2 million.
-   **Entera Bio** (NASDAQ:ENTX) shares declined by 11.24% to $1.58. The company's market cap stands at $87.6 million.
-   **GlucoTrack** (NASDAQ:GCTK) stock fell 10.59% to $0.47. The company's market cap stands at $3.3 million.
-   **Exicure** (NASDAQ:XCUR) stock fell 10.5% to $1.45. The company's market cap stands at $10.3 million.
-   **Alpha Compute** (NASDAQ:ALP) shares decreased by 10.04% to $0.29. The company's market cap stands at $7.5 million. As per the press release, FY earnings came out yesterday. **See Also:** www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

### Related Stocks

- [ATAI.US](https://longbridge.com/en/quote/ATAI.US.md)
- [DCOY.US](https://longbridge.com/en/quote/DCOY.US.md)
- [CDT.US](https://longbridge.com/en/quote/CDT.US.md)
- [ENTX.US](https://longbridge.com/en/quote/ENTX.US.md)
- [ATPC.US](https://longbridge.com/en/quote/ATPC.US.md)
- [LIMN.US](https://longbridge.com/en/quote/LIMN.US.md)
- [GHRS.US](https://longbridge.com/en/quote/GHRS.US.md)
- [VRAX.US](https://longbridge.com/en/quote/VRAX.US.md)
- [KAPA.US](https://longbridge.com/en/quote/KAPA.US.md)
- [GCTK.US](https://longbridge.com/en/quote/GCTK.US.md)
- [XCUR.US](https://longbridge.com/en/quote/XCUR.US.md)
- [ALP.US](https://longbridge.com/en/quote/ALP.US.md)
- [LIMNW.US](https://longbridge.com/en/quote/LIMNW.US.md)
- [CDTTW.US](https://longbridge.com/en/quote/CDTTW.US.md)

## Related News & Research

- [Entera Bio Rebounds As Investors Balance Phase 3 Funding Against Dilution Risk](https://longbridge.com/en/news/294234662.md)
- [Entera Bio prices USD 275 million private placement at USD 2.04 per share](https://longbridge.com/en/news/293933037.md)
- [Liminatus Pharma Reports Improved Nasdaq Listing Compliance Status](https://longbridge.com/en/news/294345322.md)
- [Liminatus Pharma awaits Nasdaq ruling after saying equity tops $2.5 million threshold](https://longbridge.com/en/news/294342373.md)
- [Decoy Therapeutics D-MAV candidate shows in vitro activity against Ebola Zaire virus](https://longbridge.com/en/news/293937063.md)